A-500 were applied to the determination of uric acid and glucose in control sera.
INTRODUCTION
In clinical analyses many enzymatic methods are routinely used to measure various vital compounds. 1) For example, uric acid and glucose are indirectly determined by measuring the amounts of H 2 O 2 produced through reactions (1) and (2) catalyzed by uricase and glucoseoxidase (GOD), respectively. In general, the amount of H 2 O 2 produced was spectrophotometrically determined by measuring an amount of quinoid dye produced through reaction (3) 
However, most enzymes generally have problems regarding stability, handling and storage. In an effort to develop an artificial mimesis to solve these problems, we have investigated the enzyme-like activities of metal complexes of thiacalix [4] arenetetrasulfonate on a modified anion-exchanger (Me-TCAS [4] A-500 ). [2] [3] [4] [5] We have shown that Fe 3+ -TCAS [4] A-500 exhibited strong peroxidase-like activity for reaction (3) and was useful as a peroxidase mimic for the spectrophotometric determination of H 2 O 2 and glucose in control sera. 2, 3) Moreover, we have demonstrated that Fe 3+ -TCAS [4] A-500 exhibited strong catalytic activity for oxidation (4) The peroxidase-like activity of the Fe 3+ complex of thiacalix [4] arenetetrasulfonate on a modified anion-exchanger (Fe 3+ -TCAS [4] A-500 ) has been applied to the spectrofluorometric determination of uric acid and glucose in connection with uricase and glucoseoxidase (GOD), respectively. Uric acid and glucose were spectrofluorometrically determined by measuring the amounts of H 2 O 2 produced through each catalytic reaction by uricase and GOD for uric acid and glucose in a sample solution, respectively. The calibration curves obtained by the Uricase-Fe 3+ -TCAS [4] A-500 and the GOD-Fe 3+ -TCAS [4] A-500 methods were linear from 0.5 to 5.0 µg of uric acid in a 1.0 ml sample solution and from 0.5 to 6.0 µg of glucose in a 0.5 ml sample solution, respectively. The methods using Fe corresponding reaction by peroxidase.), and was useful as a peroxidase mimic for the spectrofluorometric determination of a trace amount of H 2 O 2 .
5)
In clinical analyses, it is necessary to develop a more sensitive method for the determination of vital compounds so as to minimize the amount of vital samples. In this study, the peroxidase-like catalytic activity of Fe 3+ -TCAS [4] A-500 for oxidative reaction (4) was applied to the spectrofluorometric determination of uric acid and glucose in connection with uricase and GOD, respectively. To date, spectrofluorometric methods using various enzymes have been developed for the determination of uric acid 6) and glucose. [7] [8] [9] [10] However, no report has been published on the spectrofluorometric method using a peroxidase mimic such as Fe 3+ -TCAS [4] A-500 .
MATERIALS AND METHODS
Reagents ---Sodium thiacalix [4] arenetetrasulfonate (TCAS [4] , Fig. 1 4 OH for pH 8.5-11.0, and 0.1 M NaHCO 3 -0.05 M Na 2 CO 3 for pH 9.0-11.5. Instruments ---The fluorescence intensities were recorded on a Shimadzu RF-5300 spectrofluorometer with a quartz cell (1 × 1 cm cross-section) equipped with a xenon lamp and dual monochromator.
Procedure ---
Uricase-Fe 3+ -TCAS [4] A-500 Method for Uric Acid: Uric acid was determined with a combination of reactions (1) and (4) buffer solution (3.0 ml); the mixture was incubated at 40°C for 30 min. After Fe 3+ -TCAS [4] A-500 was filtered off, the fluorescence intensity of the supernatant was measured.
Uricase-POD Method for Uric Acid as a Reference: A mixture of sample solution (1.0 ml), uricase solution (1.0 ml, 1.25 U/ml), POD solution (0.5 ml, 10 U/ml), 40 mM p-acetoamidophenol solution (1.0 ml) and buffer solution (2.5 ml) was incubated at room temperature for 30 min. The fluorescence intensity of this reaction solution was measured.
GOD-Fe 3+ -TCAS [4] A-500 Method for Glucose: Glucose was determined with a combination of reactions (2) and (4) catalyzed by GOD and Fe 3+ -TCAS [4] A-500 , respectively. First, a mixture containing sample solution (0.5 ml, 0.5-6.0 µg of glucose), GOD solution (0.5 ml, 32 U/ml), and acetate buffer solution of pH 5.0 (0.5 ml) was incubated at 40°C for 10 min. Next, 40 mM p-acetoamidophenol solution (2.0 ml), carbonate buffer solution of pH 10.25 (2.5 ml) and Fe 3+ -TCAS [4] A-500 (20 mg) were added and the mixture was incubated at 40°C for 20 min. After Fe 3+ -TCAS [4] A-500 was filtered off, the fluorescence intensity of the supernatant was measured.
GOD-POD Method for Glucose as a Reference:
A mixture of sample solution (0.5 ml), GOD solution (0.5 ml, 32 U/ml), POD solution (0.5 ml, 10 U/ ml), 40 mM p-acetoamidophenol solution (2.0 ml) and buffer solution (2.5 ml) was incubated at room temperature for 20 min. The fluorescence intensity of this reaction solution was measured.
Removal of Serum Proteins from Control Sera: A mixture of serum (2.0 ml), 2/3 N H 2 SO 4 (1.0 ml) and 10 g/dl sodium tungstate (1.0 ml) was vigorously shaken for 10 min and then centrifuged at 3000 rpm for 10 min. The supernatant (1.0 ml) of this reaction mixture was used as a sample solution.
RESULTS AND DISCUSSION

Investigation of Optimum Conditions for the Determination of Uric Acid
For the determination of uric acid, uricase (from Candida sp.) and Fe 3+ -TCAS [4] A-500 were simultaneously added to a sample solution. However, the optimum pH for each of their activities differed slightly. The optimum pH of uricase (from Candida sp.) is about 8, whereas Fe 3+ -TCAS [4] A-500 exhibited its maximum catalytic activity for reaction (4) at around pH 10, as described previously.
5) Accordingly, to establish the optimum conditions, experiments were carried out using the Uricase-Fe 3+ -TCAS [4] A-500 method with 4 µg of uric acid.
Effects of pH
The activity of the Uricase-Fe 3+ -TCAS [4] A-500 was investigated in various buffer solutions. Figure 2 shows the fluorescence intensities of the solutions obtained through reactions (1) and (4) by uricase and Fe 3+ -TCAS [4] A-500 in each solution. As previously described, 5) Fe 3+ -TCAS [4] A-500 exhibited its maximum peroxidase-like activity for oxidative reaction (4) at around pH 10. As shown in Fig. 2 , Uricase-Fe 3+ -TCAS [4] A-500 exhibited high levels of activity in alkali buffer solutions, especially in a carbonate buffer solution of pH 10-11.5. Accordingly, a carbonate buffer solution of pH 10.5 was selected for the determination of uric acid with the Uricase-Fe 3+ -TCAS [4] A-500 method.
Effects of the Concentration of p-AP and Incubation Time
The concentration of p-AP and the incubation time affected the Uricase-Fe 3+ -TCAS [4] A-500 method. Forty mM of p-AP was the optimum concentration of the fluorogenic reagent: the fluorescence intensities were almost maximum and constant over 30 mM of p-AP, as shown in Fig. 3 . Figure 4 shows that the fluorescence intensities were near maximal and constant after 20 min of incubation. Thus, 30 min of incubation was long enough.
The Calibration Curve
Under the optimum conditions described above, a linear calibration curve was obtained between 0.5 acid in a sample solution (1.0 ml), respectively. Accordingly, the Uricase-Fe 3+ -TCAS [4] A-500 method is applicable to the determination of a trace amount of uric acid.
Effect of Foreign Substances
Interference in the Uricase-Fe 3+ -TCAS [4] A-500 method was investigated in the presence of various foreign substances. As shown in Table 1 Table 1 , the interference from these ions was markedly decreased by adding 0.5 ml of ascorbate oxidase solution (10 U/ml) and EDTA-2Na solution (7 mM) to a sample solution (1.0 ml), respectively. UA added; 4.0 µg. a) Error (%) = 100X(UA(found) − UA(added))/UA(added). b) Ascorbate oxidase was added to the sample solution. c) EDTA-2Na was added to the sample solution. and 5.0 µg of uric acid in a sample solution (1.0 ml) using the Uricase-Fe 3+ -TCAS [4] A-500 method. The correlation coefficient and the relative standard deviation (n = 4) were 0.981 and 5.5% for 4 µg of uric
Application to the Determination of Uric Acid in Sera
The Uricase-Fe 3+ -TCAS [4] A-500 method was applied to determine uric acid in control serum I (normal) and II (abnormal). As this technique was affected by HSA, the sample solution after the removal of serum proteins in control sera was applied to the determination. As shown in Table 2 , the observed amounts of uric acid obtained with the Uricase-Fe 3+ -TCAS [4] A-500 method were just a little lower than those with the Uricase-POD method as a reference. This may be the reason why the simultaneous reaction efficiency of uricase and Fe 3+ -TCAS [4] A-500 is not always adequate. However, the results with the present method were satisfactory for both control serum I and II.
Investigation of Optimum Conditions for the Determination of Glucose
Similar to uric acid, glucose was determined by measuring the fluorescence intensity of the reaction solution through reactions (2) and (4) [4] A-500 , for example, the pH of the sample solution, concentration of p-AP, and incubation temperature and time, were the same as those 5) for the determination of H 2 O 2 using Fe 3+ -TCAS [4] A-500 . The calibration curve was straight for sample solutions (0.5 ml) containing 0.5-6.0 µg of glucose, and the correlation coefficient and relative standard deviation (n = 4) were 0.985 and 4.9% for 5.0 µg of glucose, respectively. The sensitivity of the present method was 10-100 times higher than those of the spectrophotometric methods we previously developed using Fe 3+ -TCAS [4] A-500 .
2,3)
Moreover, the GOD-Fe 3+ -TCAS [4] A-500 method was applied to the determination of glucose in control sera I and II, whose sample solutions were applied after being diluted 20 and 100 times with distilled water, respectively. This technique required no removal of serum proteins such as HSA from control sera. This may be because the concentration of HSA decreased substantially on dilution of the sera. As shown in Table 3 , the observed amounts of glucose obtained for both control serum I and II were satisfactory, compared with the GOD-POD method as a reference.
In conclusion, the peroxidase-like activity of Fe 3+ -TCAS [4] A-500 for reaction (4) was useful for the spectrofluorometric determination of a trace amount of uric acid and glucose in connection with uricase and GOD, respectively. Moreover, these methods using Fe 3+ -TCAS [4] A-500 were also useful for the spectrofluorometric determination of a trace amount of uric acid and glucose in blood. Fe 3+ -TCAS [4] A-500 has the advantages that it can be prepared easily and used repeatedly, and exhibits sufficient activity as a peroxidase mimic even in sera. The present methods are the first successful examples performed by a peroxidase mimic, Fe 3+ -TCAS [4] A-500 , for the spec- trofluorometric determination of uric acid and glucose.
